NCT02119858View on ClinicalTrials.gov

Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 25, 2014

Primary Completion Date

February 7, 2018

Study Completion Date

February 7, 2018

Conditions
Stage IIA Prostate CancerStage IIB Prostate Cancer
Interventions
DRUG

indocyanine green solution

Given transperineally

OTHER

diffuse optical imaging

Undergo near infrared fluorescence imaging

PROCEDURE

robot-assisted laparoscopic surgery

Undergo robot-assisted laparoscopic radical prostatectomy

PROCEDURE

therapeutic lymphadenectomy

Undergo lymphadenectomy

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT02119858 - Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter